Orchid Pharma
-
December 02, 2022, Friday
Orchid Pharma board approves QIP programme to raise Rs 500 crore
Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors. The ...
-
November 28, 2022, Monday
China-Plus-One strategy: Indian API firms start to reap benefits
Rising Chinese labour costs, geopolitics, pandemic-stricken uncertainties have forced global players to derisk
-
November 24, 2022, Thursday
Orchid Pharma antibiotic product for treating UTI coming to India: MD
Company says it's returning to profit after takeover by Dhanuka Laboratories under insolvency resolution
-
November 16, 2022, Wednesday
Orchid Pharma Q2 EBIDTA rises 104%, revenue up 36% on increasing sales
/ -- Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser sharp focus on costs, Orchid ...
-
February 14, 2022, Monday
Stocks to Watch: Apollo Hospitals, Nazara, DB Realty, Orchid Pharma, auto
Adani Wilmar, Coal India, Dish Tv, Eicher Motors, Grasim, Medplus Health, MTNL, Nagarjuna Fertilizers, PC Jeweller, Railtel, ...
-
June 24, 2021, Thursday
Orchid Pharma OFS subscribed 2.5x; India Pesticides IPO 3.8x on Day 2
Shares of Orchid Pharma hit 10 per cent lower limit to end at Rs 1,188 on Thursday
-
June 24, 2021, Thursday
Orchid Pharma freezes at 10% down circuit as promoter begins stake sale
Dhanuka Laboratories, one of the promoter of Orchid Pharma proposed to sell in aggregate up to 3.28 million equity shares, ...
-
June 04, 2021, Friday
After 7,700% surge in stock, Orchid Pharma to face reality check
New owners have to divest part of their stake of about 98 per cent in the firm, which re-listed in Mumbai in early November after ...
-
March 24, 2021, Wednesday
Orchid Pharma rises from ashes, expects to make profits in 12 months
Dhanuka Pharmaceuticals that took over the company almost a year ago, nursed it back to health from bankruptcy
-
March 22, 2021, Monday
This pharma stock has zoomed over 10,000% in 96 trading days
Orchid Pharma shares were locked in the upper circuit for the 96th straight trading day